ArticleScientific reports2015

Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling.

Xinqun Chai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.